The nature of the interaction of amines with the pancreatic beta cell to influence insulin secretion.
D000588:Amines / Q000494:pharmacology*; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D002395:Catecholamines / Q000037:antagonists & inhibitors; D006224:Cricetinae; D000242:Cyclic AMP / Q000502:physiology; D003514:Cyclohexylamines / Q000494:pharmacology; D003864:Depression, Chemical; D004336:Drug Antagonism; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects*; D008297:Male; D010627:Phenethylamines / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology
D000588:Amines; D001593:Benzyl Compounds; D002395:Catecholamines; D003514:Cyclohexylamines; D006634:Histamine H1 Antagonists; D007328:Insulin; D010627:Phenethylamines; D006632:Histamine; D014044:Tolbutamide; D000242:Cyclic AMP; D010646:Phentolamine